Publicação

Effective in vivo targeting of influenza virus through a cell-penetrating/fusion inhibitor tandem peptide anchored to the plasma membrane

Ver documento

Detalhes bibliográficos
Resumo:The impact of influenza virus infection is felt each year on a global scale when approximately 5−10% of adults and 20−30% of children globally are infected. While vaccination is the primary strategy for influenza prevention, there are a number of likely scenarios for which vaccination is inadequate, making the development of effective antiviral agents of utmost importance. Anti-influenza treatments with innovative mechanisms of action are critical in the face of emerging viral resistance to the existing drugs. These new antiviral agents are urgently needed to address future epidemic (or pandemic) influenza and are critical for the immune-compromised cohort who cannot be vaccinated. We have previously shown that lipid tagged peptides derived from the C-terminal region of influenza hemagglutinin (HA) were effective influenza fusion inhibitors. In this study, we modified the influenza fusion inhibitors by adding a cell penetrating peptide sequence to promote intracellular targeting. These fusion-inhibiting peptides self-assemble into ∼15−30 nm nanoparticles (NPs), target relevant infectious tissues in vivo, and reduce viral infectivity upon interaction with the cell membrane. Overall, our data show that the CPP and the lipid moiety are both required for efficient biodistribution, fusion inhibition, and efficacy in vivo.
Autores principais:Figueira, Tiago Nascimento
Outros Autores:Augusto, Marcelo Tavares; Rybkina, K.; Stelitano, D.; Noval, M. G.; Harder, O. E.; Veiga, Ana Salome; Huey, D.; Alabi, C. A.; Biswas, S.; Niewiesk, S.; Moscona, A.; Santos, Nuno C.; Castanho, Miguel A. R. B.; Porotto, M.
Ano:2018
País:Portugal
Tipo de documento:artigo
Tipo de acesso:acesso restrito
Instituição associada:Universidade de Lisboa
Idioma:inglês
Origem:Repositório da Universidade de Lisboa
_version_ 1866810084059774976
author Figueira, Tiago Nascimento
author2 Augusto, Marcelo Tavares
Rybkina, K.
Stelitano, D.
Noval, M. G.
Harder, O. E.
Veiga, Ana Salome
Huey, D.
Alabi, C. A.
Biswas, S.
Niewiesk, S.
Moscona, A.
Santos, Nuno C.
Castanho, Miguel A. R. B.
Porotto, M.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author_facet Figueira, Tiago Nascimento
Augusto, Marcelo Tavares
Rybkina, K.
Stelitano, D.
Noval, M. G.
Harder, O. E.
Veiga, Ana Salome
Huey, D.
Alabi, C. A.
Biswas, S.
Niewiesk, S.
Moscona, A.
Santos, Nuno C.
Castanho, Miguel A. R. B.
Porotto, M.
author_role author
contributor_name_str_mv Repositório Científico de Acesso Aberto da ULisboa
country_str PT
creators_json_txt [{\"Person.name\":\"Figueira, Tiago Nascimento\",\"Person.identifier.orcid\":\"0000-0002-0813-0745\"},{\"Person.name\":\"Augusto, Marcelo Tavares\"},{\"Person.name\":\"Rybkina, K.\"},{\"Person.name\":\"Stelitano, D.\"},{\"Person.name\":\"Noval, M. G.\"},{\"Person.name\":\"Harder, O. E.\"},{\"Person.name\":\"Veiga, Ana Salome\",\"Person.identifier.orcid\":\"0000-0002-9892-2243\"},{\"Person.name\":\"Huey, D.\"},{\"Person.name\":\"Alabi, C. A.\"},{\"Person.name\":\"Biswas, S.\"},{\"Person.name\":\"Niewiesk, S.\"},{\"Person.name\":\"Moscona, A.\"},{\"Person.name\":\"Santos, Nuno C.\",\"Person.identifier.orcid\":\"0000-0002-0580-0475\"},{\"Person.name\":\"Castanho, Miguel A. R. B.\",\"Person.identifier.orcid\":\"0000-0001-7891-7562\"},{\"Person.name\":\"Porotto, M.\"}]
datacite.contributors.contributor.contributorName.fl_str_mv Repositório Científico de Acesso Aberto da ULisboa
datacite.creators.creator.creatorName.fl_str_mv Figueira, Tiago Nascimento
Augusto, Marcelo Tavares
Rybkina, K.
Stelitano, D.
Noval, M. G.
Harder, O. E.
Veiga, Ana Salome
Huey, D.
Alabi, C. A.
Biswas, S.
Niewiesk, S.
Moscona, A.
Santos, Nuno C.
Castanho, Miguel A. R. B.
Porotto, M.
datacite.date.Accepted.fl_str_mv 2018-01-01T00:00:00Z
datacite.date.available.fl_str_mv 2019-03-22T12:28:57Z
datacite.date.embargoed.fl_str_mv 2019-03-22T12:28:57Z
datacite.rights.fl_str_mv http://purl.org/coar/access_right/c_16ec
datacite.titles.title.fl_str_mv Effective in vivo targeting of influenza virus through a cell-penetrating/fusion inhibitor tandem peptide anchored to the plasma membrane
dc.contributor.none.fl_str_mv Repositório Científico de Acesso Aberto da ULisboa
dc.creator.none.fl_str_mv Figueira, Tiago Nascimento
Augusto, Marcelo Tavares
Rybkina, K.
Stelitano, D.
Noval, M. G.
Harder, O. E.
Veiga, Ana Salome
Huey, D.
Alabi, C. A.
Biswas, S.
Niewiesk, S.
Moscona, A.
Santos, Nuno C.
Castanho, Miguel A. R. B.
Porotto, M.
dc.date.Accepted.fl_str_mv 2018-01-01T00:00:00Z
dc.date.available.fl_str_mv 2019-03-22T12:28:57Z
dc.date.embargoed.fl_str_mv 2019-03-22T12:28:57Z
dc.format.none.fl_str_mv application/pdf
dc.identifier.none.fl_str_mv http://hdl.handle.net/10451/37658
dc.language.none.fl_str_mv eng
dc.publisher.none.fl_str_mv American Chemical Society
dc.rights.none.fl_str_mv http://purl.org/coar/access_right/c_16ec
dc.title.fl_str_mv Effective in vivo targeting of influenza virus through a cell-penetrating/fusion inhibitor tandem peptide anchored to the plasma membrane
dc.type.none.fl_str_mv http://purl.org/coar/resource_type/c_6501
description The impact of influenza virus infection is felt each year on a global scale when approximately 5−10% of adults and 20−30% of children globally are infected. While vaccination is the primary strategy for influenza prevention, there are a number of likely scenarios for which vaccination is inadequate, making the development of effective antiviral agents of utmost importance. Anti-influenza treatments with innovative mechanisms of action are critical in the face of emerging viral resistance to the existing drugs. These new antiviral agents are urgently needed to address future epidemic (or pandemic) influenza and are critical for the immune-compromised cohort who cannot be vaccinated. We have previously shown that lipid tagged peptides derived from the C-terminal region of influenza hemagglutinin (HA) were effective influenza fusion inhibitors. In this study, we modified the influenza fusion inhibitors by adding a cell penetrating peptide sequence to promote intracellular targeting. These fusion-inhibiting peptides self-assemble into ∼15−30 nm nanoparticles (NPs), target relevant infectious tissues in vivo, and reduce viral infectivity upon interaction with the cell membrane. Overall, our data show that the CPP and the lipid moiety are both required for efficient biodistribution, fusion inhibition, and efficacy in vivo.
dirty 0
eu_rights_str_mv restrictedAccess
format article
fulltext.url.fl_str_mv https://repositorio.ulisboa.pt/bitstreams/a379f10e-3425-4b2a-b8f2-ba76b5fd2ba2/download
funding.funder.alternateName_str_mv FCT
FCT
funding.funder.identifier_str_mv http://doi.org/10.13039/501100001871
http://doi.org/10.13039/501100001871
funding.funder.name_str_mv Fundação para a Ciência e a Tecnologia
Fundação para a Ciência e a Tecnologia
funding.name_str_mv 3599-PPCDT
3599-PPCDT
id ul_89a728c99a2c19c8a3c4bbf06f38439f
identifier.url.fl_str_mv http://hdl.handle.net/10451/37658
instacron_str ul
institution Universidade de Lisboa
instname_str Universidade de Lisboa
language eng
network_acronym_str ul
network_name_str Repositório da Universidade de Lisboa
oai_identifier_str oai:repositorio.ulisboa.pt:10451/37658
organization_str_mv urn:organizationAcronym:ul
person_str_mv Figueira, Tiago Nascimento
Figueira, Tiago Nascimento
http://orcid.org/0000-0002-0813-0745
0000-0002-0813-0745
Augusto, Marcelo Tavares
Rybkina, K.
Stelitano, D.
Noval, M. G.
Harder, O. E.
Veiga, Ana Salome
Veiga, Ana Salome
http://orcid.org/0000-0002-9892-2243
0000-0002-9892-2243
Huey, D.
Alabi, C. A.
Biswas, S.
Niewiesk, S.
Moscona, A.
Santos, Nuno C.
Santos, Nuno C.
https://www.ciencia-id.pt/CD13-5E3A-A3C5
CD13-5E3A-A3C5
http://orcid.org/0000-0002-0580-0475
0000-0002-0580-0475
Castanho, Miguel A. R. B.
Castanho, Miguel A. R. B.
http://orcid.org/0000-0001-7891-7562
0000-0001-7891-7562
Porotto, M.
publishDate 2018
publisher.none.fl_str_mv American Chemical Society
reponame_str Repositório da Universidade de Lisboa
repository_id_str urn:repositoryAcronym:ul
service_str_mv urn:repositoryAcronym:ul
spelling engAmerican Chemical Societypt_PTThe impact of influenza virus infection is felt each year on a global scale when approximately 5−10% of adults and 20−30% of children globally are infected. While vaccination is the primary strategy for influenza prevention, there are a number of likely scenarios for which vaccination is inadequate, making the development of effective antiviral agents of utmost importance. Anti-influenza treatments with innovative mechanisms of action are critical in the face of emerging viral resistance to the existing drugs. These new antiviral agents are urgently needed to address future epidemic (or pandemic) influenza and are critical for the immune-compromised cohort who cannot be vaccinated. We have previously shown that lipid tagged peptides derived from the C-terminal region of influenza hemagglutinin (HA) were effective influenza fusion inhibitors. In this study, we modified the influenza fusion inhibitors by adding a cell penetrating peptide sequence to promote intracellular targeting. These fusion-inhibiting peptides self-assemble into ∼15−30 nm nanoparticles (NPs), target relevant infectious tissues in vivo, and reduce viral infectivity upon interaction with the cell membrane. Overall, our data show that the CPP and the lipid moiety are both required for efficient biodistribution, fusion inhibition, and efficacy in vivo.application/pdfpt_PTEffective in vivo targeting of influenza virus through a cell-penetrating/fusion inhibitor tandem peptide anchored to the plasma membranePersonalFigueira, Tiago NascimentoDSpacehttp://dspace.org/items/c65d67d4-bb09-45c4-be75-376e1f048665DSpacehttp://dspace.org/items/c65d67d4-bb09-45c4-be75-376e1f048665FigueiraTiagoORCIDhttp://orcid.org0000-0002-0813-0745Augusto, Marcelo TavaresRybkina, K.Stelitano, D.Noval, M. G.Harder, O. E.PersonalVeiga, Ana SalomeDSpacehttp://dspace.org/items/e4303354-5eaa-4d48-8198-de1adc9beb19DSpacehttp://dspace.org/items/e4303354-5eaa-4d48-8198-de1adc9beb19VeigaAna SalomeORCIDhttp://orcid.org0000-0002-9892-2243Scopus Author IDhttps://www.scopus.com56745037100Huey, D.Alabi, C. A.Biswas, S.Niewiesk, S.Moscona, A.PersonalSantos, Nuno C.DSpacehttp://dspace.org/items/4656d912-5a2d-4c80-8921-2bcba3aa441aDSpacehttp://dspace.org/items/4656d912-5a2d-4c80-8921-2bcba3aa441aSantosNunoCiência IDhttps://www.ciencia-id.ptCD13-5E3A-A3C5ORCIDhttp://orcid.org0000-0002-0580-0475Researcher IDhttps://www.researcherid.comN-7248-2013Scopus Author IDhttps://www.scopus.com55940818300PersonalCastanho, Miguel A. R. B.DSpacehttp://dspace.org/items/f5e46f85-fabf-450a-9ee2-1c7b59410892DSpacehttp://dspace.org/items/f5e46f85-fabf-450a-9ee2-1c7b59410892CastanhoMiguelORCIDhttp://orcid.org0000-0001-7891-7562Scopus Author IDhttps://www.scopus.com56605575600Porotto, M.HostingInstitutionOrganizationalRepositório Científico de Acesso Aberto da ULisboae-mailmailto:repositorio@reitoria.ulisboa.ptrepositorio@reitoria.ulisboa.ptISSNIsPartOf1043-1802DOIIsPartOf10.1021/acs.bioconjchem.8b005272019-03-22T12:28:57Z20182018-01-01T00:00:00ZHandlehttp://hdl.handle.net/10451/37658http://purl.org/coar/access_right/c_16ecrestricted access6043038 bytesFundação para a Ciência e a TecnologiaTowards the development of innovative highly effective dual action anti-HIV peptides3599-PPCDTCrossref Funder IDhttp://doi.org/10.13039/501100001871Fundação para a Ciência e a TecnologiaBroad-spectrum antiviral peptides against respiratory viruses3599-PPCDTCrossref Funder IDhttp://doi.org/10.13039/501100001871literaturehttp://purl.org/coar/resource_type/c_6501journal articlehttp://purl.org/coar/access_right/c_16ecapplication/pdffulltexthttps://repositorio.ulisboa.pt/bitstreams/a379f10e-3425-4b2a-b8f2-ba76b5fd2ba2/downloadBioconjugate Chemistry2933623376
spellingShingle Effective in vivo targeting of influenza virus through a cell-penetrating/fusion inhibitor tandem peptide anchored to the plasma membrane
Figueira, Tiago Nascimento
status SINGLETON
title Effective in vivo targeting of influenza virus through a cell-penetrating/fusion inhibitor tandem peptide anchored to the plasma membrane
title_full Effective in vivo targeting of influenza virus through a cell-penetrating/fusion inhibitor tandem peptide anchored to the plasma membrane
title_fullStr Effective in vivo targeting of influenza virus through a cell-penetrating/fusion inhibitor tandem peptide anchored to the plasma membrane
title_full_unstemmed Effective in vivo targeting of influenza virus through a cell-penetrating/fusion inhibitor tandem peptide anchored to the plasma membrane
title_short Effective in vivo targeting of influenza virus through a cell-penetrating/fusion inhibitor tandem peptide anchored to the plasma membrane
title_sort Effective in vivo targeting of influenza virus through a cell-penetrating/fusion inhibitor tandem peptide anchored to the plasma membrane
url http://hdl.handle.net/10451/37658
visible 1